Precipitation of submicron particles of rutin using supercritical antisolvent process

Journal of Supercritical Fluids

Volumn 118, Issue , 2016, Pages 1-10

  Montes, A ^a   Wehner, L ^b   Pereyra, C ^a   Martinez de la Ossa E J ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b NUREMBERG INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Amorphization; Rutin; Submicron particle; Supercritical antisolvent

Indexed keywords

ACETONE; ALCOHOLS; AMORPHIZATION; CARBON DIOXIDE; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PARTICLE SIZE; PRECIPITATION (CHEMICAL); SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

INITIAL CONCENTRATION; PARTICLE SIZE REDUCTION; PRECIPITATION PROCESS; RUTIN; SUB-MICRON PARTICLES; SUPERCRITICAL ANTISOLVENT PROCESS; SUPERCRITICAL ANTISOLVENTS; TEMPERATURE AND PRESSURES;

SUPERCRITICAL FLUID EXTRACTION;

EID: 84979943836     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2016.07.020     Document Type: Article

References (49)

1. [1] Hemalatha, P., Bomzan, D.P., Rao, B.V.S., Sreerama, Y.N., Distribution of phenolic antioxidants in whole and milled fractions of quinoa and their inhibitory effects on a-amylase and a-glucosidase activities. Food Chem. 199 (2016), 330–338.
2. [2] Makrisa, D.P., Boskou, G., Andrikopoulos, N.K., Polyphenolic content and in vitro antioxidant characteristics of wine industry and other agri-food solid waste extracts. J. Food Compos. Anal. 20 (2007), 125–132.
3. [3] Jan, S., Khan, M.R., Antipyretic, analgesic and anti-inflammatory effects of Kickxia ramosissima. J. Ethnopharmacol. 182 (2016), 90–100.
4. [4] Abou-Elella, F., Mourad, R., Anticancer and anti-oxidant potentials of ethanolic extracts of Phoenix dactylifera, Musa acuminata and Cucurbita maxima. Res. J. Pharm. Biol. Chem. Sci. 6:1 (2015), 710–720.
5. [5] Govea-Salas, M., Rivas-Estilla, A.M., Rodríguez-Herrera, R., Lozano-Sepúlveda, S.A., Aguilar-Gonzalez, C.N., Zugasti-Cruz, A., Salas-Villalobos, T.B., Morlett-Cháve, J.A., Gallic acid decreases hepatitis C virus expression through its antioxidant capacity. Exp. Ther. Med. 11:2 (2016), 619–624.
6. [6] Rashad, M.M., Mahmoud, A.E., Ali, M.M., Nooman, M.U., Al-Kashef, A.S., Antioxidant and anticancer agents produced from pineapple waste by solid state fermentation. Int. J. Toxicol. Pharmacol. Res. 7:6 (2015), 287–296.
7. [7] Calabró, M.L., Tommasini, S., Donato, P., Stancanelli, R., Raneri, D., Catania, S., Costa, C., Villari, V., Ficarra, P., Ficarra, R., The rutin/β-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J. Pharm. Biomed. Anal. 36 (2005), 1019–1027.
8. [8] Kreft, I., Fabjan, N., Yasumoto, K., Rutin content in buckwheat (Fagopyrum esculentum Moench) food materials and products. Food Chem. 98 (2006), 508–512.
9. [9] Kamel, R., Mostafa, D.M., Rutin nanostructured lipid cosmeceutical preparation with sun protective potential. J. Photochem. Photobiol. B: Biol. 153 (2015), 59–66.
10. [10] Hooresfand, Z., Ghanbarzadeh, S., Hamishehkar, H., Preparation and characterization of rutin-loaded nanophytosomes. Pharm. Sci. 21:3 (2015), 145–151.
11. [11] Yu, S.H., Yu, J.M., Yoo, H.J., Lee, S.J., Kang, D.H., Cho, Y.J., Kim, D.M., Anti-proliferative effects of rutin on OLETF rat vascular smooth muscle cells stimulated by glucose variability. Yonsei Med. J. 57:2 (2016), 373–381.
12. [12] Magalingam, K.B., Radhakrishnan, A., Haleagrahara, N., Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells. Int. J. Immunopathol. Pharmacol. 29:1 (2015), 30–39.
13. [13] Tian, R., Yang, W., Xue, Q., Gao, L., Huo, J., Ren, D., Chen, X., Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats. Eur. J. Pharmacol. 771 (2016), 84–92.
14. [14] Vankudri, R., Habbu, P., Hiremath, M., Patil, B.S., Savant, C., Preparation and therapeutic evaluation of rutin-phospholipid complex for antidiabetic activity. J. Appl. Pharm. Sci. 6:1 (2016), 90–101.
15. [15] Fraile, M., Buratto, R., Gómez, B., Martín, A., Cocero, M.J., Enhanced delivery of quercetin by encapsulation in poloxamers by supercritical antisolvent process. Ind. Eng. Chem. Res. 53 (2014), 4318–4327.
16. [16] Patila, A.G., Jobanputra, A.H., Rutin-Chitosan nanoparticles: fabrication characterization and application in dental disorders. Polym. Plast. Technol. Eng. 54:2 (2015), 202–208.
17. [17] Macedo, A.S., Quelhas, S., Silva, A.M., Souto, E.B., Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug. Pharm. Dev. Technol. 19:6 (2014), 677–680.
18. [18] Konecsni, K., Low, N.H., Nickerson, M.T., Chitosan–tripolyphosphate submicron particles as the carrier of entrapped rutin. Food Chem. 134 (2012), 1775–1779.
19. [19] Mauludin, R., Müller, R.H., Keck, C.M., Development of an oral rutin nanocrystal formulation. Int. J. Pharm. 370 (2009), 202–209.
20. [20] Jójárt-Laczkovich, O., Szabó-Révész, P., Amorphization of a crystalline active pharmaceutical ingredient and thermoanalytical measurements on this glassy form. J. Therm. Anal. Calorim. 102 (2010), 243–247.
21. [21] Jung, J., Perrut, M., Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids 20:3 (2001), 179–219.
22. [22] Martín, A., Cocero, M.J., Precipitation processes with supercritical fluids: patents review. Recent Pat. Eng. 2 (2008), 9–20.
23. [23] Santos, D.T., Meireles, M.A.A., Micronization and encapsulation of functional pigments using supercritical carbon dioxide. J. Food Process. Eng. 36 (2013), 36–49.
24. 2 + ethanol as a modifier: measurements and thermodynamic modelling. J. Supercrit. Fluids 32 (2004), 89–96.
25. [25] Montes, A., Pereyra, C., Martínez de la Ossa, E.J., Screening design of experiment applied to the supercritical antisolvent precipitation of quercetin. J. Supercrit. Fluids 104 (2015), 10–18.
26. [26] Martín, A., Cocero, M.J., Micronization processes with supercritical fluids: fundamentals and mechanisms. Adv. Drug Deliv. Rev. 60 (2008), 339–350.
27. [27] Reverchon, E., De Marco, I., Torino, E., Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. J. Supercrit. Fluids 43 (2007), 126–138.
28. [28] De Marco, I., Knauer, O., Cice, F., Braeuer, A., Reverchon, E., Interactions of phase equilibria: jet fluid dynamics and mass transfer during supercritical antisolvent micronization: the influence of solvents. Chem. Eng. J. 203 (2012), 71–80.
29. [29] Kim, C.K., Lee, B.C., Lee, Y.W., Kim, H.S., Solvent effect on particle morphology in recrystallization of HMX (cyclotetramethylenetetranitramine) using supercritical carbon dioxide as antisolvent. Korean J. Chem. Eng. 26 (2010), 1125–1129.
30. [30] Liu, G., Wang, H., Jiang, Y., Recrystallization and micronization of camptothecin by the supercritical antisolvent process: influence of solvents. Ind. Eng. Chem. Res. 52 (2013), 15049–15056.
31. [31] Tenorio, A., Gordillo, M.D., Pereyra, C.M., Martínez de la Ossa, E.M., Relative importance of the operating conditions involved in the formation of nanoparticles of ampicillin by supercritical antisolvent precipitation. Ind. Eng. Chem. Res. 46 (2007), 114–123.
32. [32] Reverchon, E., Torino, E., Dowy, S., Braeuer, A., Leipertz, A., Interactions of phase equilibria, jet fluid dynamics and mass transfer during supercritical antisolvent micronization. Chem. Eng. J. 156 (2010), 446–458.
33. [33] Zhu, Y.-F., Shi, J.-L., Li, Y.-S., Chen, H.-R., Shen, W.-H., Dong, X.-P., Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Microporous Mesoporous Mater. 85 (2005), 75–81.
34. [34] Vega Gonzalez, A., Tufeu, R., Subra, P., High-pressure vapor-liquid equilibrium for the binary systems carbon dioxide + dimethyl sulfoxide and carbon dioxide + dichloromethane. J. Chem. Eng. Data 47 (2002), 492–495.
35. [35] Kalogiannis, C.G., Pavlidou, E., Panayiotou, C.G., Production of amoxicillin microparticles by supercritical antisolvent precipitation. Ind. Eng. Chem. Res. 44 (2005), 9339–9346.
36. [36] Reverchon, E., De Marco, I., Supercritical antisolvent precipitation of Cephalosporins. Powder Technol. 164 (2006), 139–146.
37. [37] Reverchon, E., Della Porta, G., Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation. Powder Technol. 106 (1999), 23–29.
38. [38] Martin, A., Cocero, M.J., Numerical modeling of jet hydrodynamics mass transfer, and crystallization kinetics in the supercritical antisolvent (SAS) process. J. Supercrit. Fluids 32 (2004), 203–219.
39. [39] Snavely, W.K., Subramaniam, B., Rajewski, R.A., Defelippis, M.R., Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent. J. Pharm. Sci. 91 (2002), 2026–2039.
40. [40] Reverchon, E., Della Porta, G., Falivene, M.G., Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent precipitation. J. Supercrit. Fluids 17 (2000), 239–248.
41. [41] Montes, A., Tenorio, A., Gordillo, M.D., Pereyra, C., Martínez de la Ossa, E.J., Screening design of experiment applied to supercritical antisolvent precipitation of amoxicillin: exploring new miscible conditions. J. Supercrit. Fluids 51 (2010), 399–403.
42. [42] Montes, A., Tenorio, A., Gordillo, M.D., Pereyra, C., Martínez de la Ossa, E., Supercritical antisolvent precipitation of ampicillin in complete miscibility conditions. Ind. Eng. Chem. Res. 50 (2011), 2343–2347.
43. [43] Ying, L., Yibin, Y., Hanbing, W., Fengguang, Z., Effect of process parameters on the recrystallization and size control of puerarin using the supercritical fluid antisolvent process. Asian J. Pharm. Sci. 11 (2016), 281–291.
44. [44] Kamel, R., Basha, M., Preparation and in vitro evaluation of rutin nanostructured liquisolid delivery system. Bull. Fac. Pharm. Cairo Univ. 51 (2013), 261–272.
45. [45] Jiang, Y., Sun, W., Wang, W., Recrystallization and micronization of 10-Hydroxycamptothecin by supercritical antisolvent process. Ind. Eng. Chem. Res. 51 (2012), 2596–2602.
46. [46] Alessi, P., Cortesi, A., de Zordi, N., Gamse, T., Kikic, I., Moneghini, M., Solinas, D., Supercritical antisolvent precipitation of quercetin systems: preliminary experiments. Chem. Biochem. Eng. Q. 26 (2012), 391–398.
47. [47] Chebil, L., Humeau, C., Anthoni, J., Dehez, F., Engasser, J.-M., Ghoul, M., Solubility of flavonoids in organic solvents. J. Chem. Eng. Data 52:5 (2007), 1552–1556.
48. [48] Das, M.K., Kalita, B., Design and evaluation of phyto-phospholipid complexes (phytosomes) of rutin for transdermal application. J. Appl. Pharm. Sci. 4:10 (2014), 51–57.
49. [49] Kim, J.-S., Kim, M.-S., Park, H.J., Jin, S.-J., Lee, S., Hwang, S.-J., Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int. J. Pharm. 359:1–2 (2008), 211–219.